Overview

VivoSense develops digital endpoints from wearable devices to enhance clinical trials. By capturing and processing data from these devices, VivoSense transforms raw sensor information into meaningful insights that improve the accuracy and reliability of trials. The company serves pharmaceutical companies, biotech firms, and research institutions, providing a full range of services including data design, collection, cleaning, analysis, and reporting. This comprehensive approach allows clients to monitor patient health and treatment outcomes in real-time. VivoSense stands out from competitors by focusing specifically on the integration of wearable technology and advanced data analytics in clinical trials. The goal is to optimize clinical trials, leading to more effective treatments and better patient outcomes.

Simplify's Take

What believers are saying

• Increased adoption of remote monitoring boosts demand for VivoSense's analytics solutions.
• Patient-centric trial approaches create opportunities for VivoSense's personalized digital endpoints.
• Wearable tech expansion leads to data surge, necessitating VivoSense's advanced analytics.

What critics are saying

• Emerging competitors like Vitasense threaten VivoSense's market share in wearable sensors.
• Rapid tech advancements may increase VivoSense's R&D costs to maintain competitiveness.
• New leadership could disrupt operations or client relationships at VivoSense.

What makes VivoSense unique

• VivoSense specializes in transforming raw sensor data into auditable digital endpoints.
• The company offers end-to-end services for wearable technology in clinical trials.
• VivoSense focuses on patient-centric digital endpoints, enhancing trial accuracy and reliability.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$27M

Above

Industry Average

Funded Over

2 Rounds

$25,000,000

Series A

Mar 2022

Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.

Series A Funding Comparison

Above Average

Industry standards

Ind Avg. $15M

$3.7M

$5M

$8.2M

$15M

$25M

$30M

View all funding stages